Xentech
  • Home
  • About XENTECH
    • Management
    • Our team
    • Facilities
    • Careers
  • Preclinical services
    • PDX models
    • Project design optimization
    • In vitro
    • In vivo
    • Biomarker discovery
    • Mouse trials
  • Press and Events
    • News
    • Publications
  • Partnerships
  • Contact
    • Location

Articles associés au tag targeted therapy

  • 8 février 2018 - The Match-R PDX project

    XenTech launches a new line of PDX models of acquired resistance to last generation targeted therapies   Development of 75 PDX models from patients with acquired resistance to latest targeted drugs A preclinical platform to identify resistance mechanisms and develop new therapeutic strategies   Background: Patients whose tumor harbor specific driver molecular alterations benefit from […]
  • 30 janvier 2014 - February 18-19th, 2014 | Frankfurt, Germany | World ADC

    Antibody drug conjugates are an emerging class of biotherapeutics which has demonstrated a significant impact on clinical practice, highlighting the potential of this new class of targeted therapies. The World ADC Frankfurt 2014 is a great opportunity to discuss strategies, relevant achievements and remaining challenges to get ADCs into clinic.   Thanks to its outstanding […]

 

  •   Home
  • |
  • About XENTECH
  • |
  • Preclinical services
  • |
  • Press and events
  • |
  • Contact
  • |
  • LinkedIn
  • |
  • Twitter

© copyright 2012 Xentech  -  Term of use

 

 

 

 

www.xentech.eu is edited by XENTECH.

 

XENTECH
4 rue Pierre Fontaine
91000 Evry
FRANCE

 

Director of publication : Sabrina SERPILLON

 

Hosted by : GENOPOLE

 

Webdesign : UMAPS Communication



Copyright notice
This Website www.xentech.eu is the property of and copyrighted by XenTech SAS, located in Pépinière GENOPOLE Entreprises - 4 rue Pierre Fontaine - 91100 Evry - France.

Intellectual Property
In accordance with the laws currently in force, the presentation and content of the Web site www.xentech.eu are the property of XenTech SAS. All reproduction, use and/or modification made, be it whole or in part, without the prior written permission of XenTech SAS, is liable to constitute an infringement of copyright. Logos, drawings, photographs, images, texts, video sequences, with or without sound, and other documents posted on the current Internet site are subject to industrial and/or intellectual property laws in the name of XenTech SAS. As such, any reproduction, representation, adaptation, translation and/or transformation, be it whole or in part, or transfer to another site are prohibited.

Limitation of liability
Access to this Web site and use of it are at the user's own risk. The information on this Internet Site is to the best of our knowledge true, complete and updated. However, the content, materials, information and software in this Web site are provided "as is" without warranty of any kind, either express or implied. XenTech SAS may change or delete information on this Web site or to stop the operation of the site without notice at any time. XenTech SAS shall not be liable for any direct, indirect, special or incidental damages arising out of access to or use of any content of this site or sites linked to this site.

Links to Third Party Sites
This site may contain links to other Web Sites maintained by parties other than XenTech SAS. The linked sites are not under the control of XenTech SAS who shall not be liable for the content of any linked site, their performance, or any changes or updates to a linked site. XenTech SAS is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by XenTech SAS of the site or any association with its operators.

Jurisdiction
Through the use of this site, the user consents to the exclusive jurisdiction of the courts of the country where there is XenTech SAS business residence for any cause of action relating to the use or content of this site.